TNFRSF11A and prostate carcinoma: To evaluate if RANKL-RANK pathway activation in RANK+ breast and prostate cancer cells could alter MMP-1 levels, we analyzed MMP-1 expression at both mRNA and protein levels upon RANKL stimulus.